Such studies would not only provide mechanistic validation but also enhance the translational significance of UBA7 as a potential therapeutic target and prognostic biomarker, paving the way for the development of targeted therapies and personalized treatment strategies in hematologic malignancies and beyond. The gene discussed is UBA7; the disease is hematologic disorder.